The study involved 486 people age 60 to 90 who had no dementia. Of those, 134 people had experienced at least one episode of depression that prompted them to seek medical advice.
The participants were followed for an average of six years. During that time 33 people developed Alzheimer’s disease. People who had experienced depression were 2.5 times more likely to develop Alzheimer’s disease than people who had never had depression. The risk was even higher for those whose depression occurred before the age of 60; they were nearly four times more likely to develop Alzheimer’s than those with no depression.
“We don’t know yet whether depression contributes to the development of Alzheimer’s disease or whether another unknown factor causes both depression and dementia,” said study author Monique M.B. Breteler, MD, PhD, with the Erasmus University Medical Center in Rotterdam, the Netherlands. “We’ll need to do more studies to understand the relationship between depression and dementia.”
One theory was that depression leads to loss of cells in two areas of the brain, the hippocampus and the amygdala, which then contributes to Alzheimer’s disease. But this study found no difference in the size of these two brain areas between people with depression and people who had never had depression.
The study also assessed whether the participants had symptoms of depression at the start of the study. But those with depressive symptoms at the start of the study were not more likely to develop Alzheimer’s than those with no depression at the start of the study.
The study was supported by the Netherlands Organization for Scientific Research and the Health Research and Development Council.
The American Academy of Neurology, an association of more than 21,000 neurologists and neuroscience professionals, is dedicated to improving patient care through education and research. A neurologist is a doctor with specialized training in diagnosing, treating and managing disorders of the brain and nervous system such as stroke, Alzheimer’s disease, epilepsy, Parkinson’s disease, and multiple sclerosis.
Angela Babb | American Academy of Neurology
Disarray in the brain
18.12.2017 | Universität zu Lübeck
Amputees can learn to control a robotic arm with their minds
28.11.2017 | University of Chicago Medical Center
A study carried out by an international team of researchers and published in the journal Physical Review X shows that ion-trap technologies available today are suitable for building large-scale quantum computers. The scientists introduce trapped-ion quantum error correction protocols that detect and correct processing errors.
In order to reach their full potential, today’s quantum computer prototypes have to meet specific criteria: First, they have to be made bigger, which means...
Since 2016, German and Spanish researchers, among them scientists from the University of Göttingen, have been hunting for exoplanets with the “Carmenes”...
DNA molecules that follow specific instructions could offer more precise molecular control of synthetic chemical systems, a discovery that opens the door for engineers to create molecular machines with new and complex behaviors.
Researchers have created chemical amplifiers and a chemical oscillator using a systematic method that has the potential to embed sophisticated circuit...
MPQ scientists achieve long storage times for photonic quantum bits which break the lower bound for direct teleportation in a global quantum network.
Concerning the development of quantum memories for the realization of global quantum networks, scientists of the Quantum Dynamics Division led by Professor...
Researchers have developed a water cloaking concept based on electromagnetic forces that could eliminate an object's wake, greatly reducing its drag while...
11.12.2017 | Event News
08.12.2017 | Event News
07.12.2017 | Event News
18.12.2017 | Physics and Astronomy
18.12.2017 | Studies and Analyses
18.12.2017 | Medical Engineering